MLYS vs YUM · $2.17B cap vs P/E 29, rev $2.17B
Mineralys Therapeutics, Inc. Common Stock (MLYS) versus Yum! Brands Inc (YUM) — a side-by-side from cached financials, not a winner call.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Yum! Brands Inc (YUM) is a restaurants company listed on US.
MLYS does not have a complete income-statement cache yet.
Latest reported YUM revenue for 2026-06-30 was $2.17B. Net income was $853.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. YUM currently screens at market cap $41.43B and trailing P/E 29.4.
MLYS currently screens at market cap $2.17B. YUM currently screens at market cap $41.43B and trailing P/E 29.4.
Not investment advice. Open the MLYS and YUM stock pages for the full models.
Not investment advice.